Value-based cancer care platform Thyme Care announced it secured $60 million in Series B funding co-led by Foresite Capital and Town Hall Ventures, bringing its total raise to over $80 million.
Current investors Andreessen Horowitz BIO + Health, Casdin Capital, Frist Cressey Ventures and AlleyCorp participated in the round.
Town Hall Ventures' cofounder and general partner David Whelan will...